tci Medicare Compliance & Reimbursement - 2003 Issue 21

Pharmaceuticals: DRUG REBATE EXPERIMENT WEATHERS HIGH COURT CHALLENGE

A state program that could point toward lower reimbursement for the nation's drugmakers came one step closer to implementation April 19. The U.S. Supreme Court lifted an injunction on "Maine Rx," a program designed to provide access to prescription drugs to Maine residents who aren't eligible for Medicaid. Under the program, state officials can impose a Medicaid prior-authorization requirement on products manufactured by drugmakers who don't give the state substantial rebates on Maine Rx-related purchases. Other states have been closely watching the case as they look for ways to expand access to drugs without breaking the bank...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.